John W. Davies

John brings over 25 years of expertise in creating and leading diverse technology teams and has mentored some of the best computational scientists in the industry. Most recently, John served as the Chief Technology Officer of Kaleido Bioscience, where he created and led the new technology platform group comprising computational biology, software engineering, compound management, and lab robotics. Prior to Kaleido, he helped reshape the data and computational strategy at Novartis and developed several unique industry-leading computational approaches, which resulted in more than 100 publications across the informatics group.

John received his Ph.D. in synthetic organic chemistry from University College London before embarking on postdoctoral studies in the then-emerging field of computational chemistry at GlaxoSmithKline.